HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Probiotics and Prebiotics in Prevention of Infectious Complications Following Hepatic Resections: Systematic Review and Meta-Analysis.

AbstractBACKGROUND AND AIMS:
Infections occurring after hepatic resection cause significant morbidity, mortality, and prolonged hospitalization. Probiotics and prebiotics are considered to offer protection against post-operative infections. We aimed to determine the effect of probiotics and prebiotics on the post-operative infection rate after hepatic resection by conducting a systematic review and a meta-analysis.
METHOD:
We searched various databases, namely, the PubMed, Medline, Embase, and Cochrane Controlled Trials Registry (CENTRAL), for randomized controlled trials evaluating the effect of probiotics and/or prebiotics on the infection rate following hepatic resection. Extracted data were pooled and subsequently used in a meta-analysis with a random-effects model. Review was reported following the PRISMA guidelines.
RESULTS:
A total of 4 studies comprising 205 patients were included for our meta-analysis. The infection rates in the probiotic group and placebo group were 11.7% and 30.3%, respectively (p<0.001). The pooled risk ratio (RR) was 0.41 (95% confidence interval [CI]: 0.128-0.730). Subgroup analysis indicated that the wound infection rate in the probiotic group (5.3%) was significantly lower than that in the placebo group (RR: 0.387, 95% CI: 0.155-0.970, p=0.043). Furthermore, probiotics/prebiotics decreased the duration of hospital stay (-0.57 days; 95% CI: -0.861 to -0.274; p<0.001) and antibiotic use (mean difference: -3.89 days, 95% CI: -4.17 to -3.60; p<0.001). There was no significant statistical heterogeneity.
CONCLUSION:
Our findings show that administration of probiotics and/or prebiotics prior to operation day decreases the infection rate post-liver resection and could shorten the duration of hospitalization and antibiotics use.
AuthorsYu Gan, Song Su, Bo Li, Chen Fang
JournalJournal of gastrointestinal and liver diseases : JGLD (J Gastrointestin Liver Dis) Vol. 28 Pg. 205-211 (Jun 01 2019) ISSN: 1842-1121 [Electronic] Romania
PMID31204407 (Publication Type: Meta-Analysis, Systematic Review)
Chemical References
  • Anti-Bacterial Agents
  • Prebiotics
Topics
  • Anti-Bacterial Agents (administration & dosage)
  • Bacterial Infections (prevention & control)
  • Bias
  • Drug Administration Schedule
  • Hepatectomy
  • Humans
  • Length of Stay (statistics & numerical data)
  • Liver Neoplasms (surgery)
  • Postoperative Complications (prevention & control)
  • Prebiotics
  • Preoperative Care (methods)
  • Probiotics (therapeutic use)
  • Randomized Controlled Trials as Topic (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: